• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.染色体缺失中一组协同作用的抑癌候选基因。
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8212-7. doi: 10.1073/pnas.1206062109. Epub 2012 May 7.
2
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.DLC1是一种位于8号染色体短臂的肿瘤抑制基因,其缺失会促进肝细胞癌的发生。
Genes Dev. 2008 Jun 1;22(11):1439-44. doi: 10.1101/gad.1672608.
3
LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma.LFIRE-1/HFREP-1是一种肝脏特异性基因,在肝细胞癌中经常下调并具有生长抑制活性。
Oncogene. 2004 Mar 11;23(10):1939-49. doi: 10.1038/sj.onc.1207306.
4
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma.鉴定8号染色体p臂上的MSRA基因作为人乙型肝炎病毒阳性肝细胞癌的候选转移抑制基因。
BMC Cancer. 2007 Sep 4;7:172. doi: 10.1186/1471-2407-7-172.
5
HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.位于8号染色体短臂上的HTPAP基因是人类肝细胞癌的一个潜在转移抑制基因。
Oncogene. 2006 Mar 16;25(12):1832-40. doi: 10.1038/sj.onc.1209191.
6
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.组蛋白甲基转移酶 G9a 通过表观遗传沉默肿瘤抑制基因 RARRES3 促进肝癌的发展。
J Hepatol. 2017 Oct;67(4):758-769. doi: 10.1016/j.jhep.2017.05.015. Epub 2017 May 19.
7
A decade's studies on metastasis of hepatocellular carcinoma.关于肝细胞癌转移的十年研究。
J Cancer Res Clin Oncol. 2004 Apr;130(4):187-96. doi: 10.1007/s00432-003-0511-1. Epub 2003 Dec 18.
8
A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients.GATA4 增强的肿瘤抑制模块为 GATA4 缺乏的 HCC 患者提供了治疗机会。
Theranostics. 2020 Jan 1;10(2):484-497. doi: 10.7150/thno.38060. eCollection 2020.
9
Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.胆淤积性肝损伤和肝癌中 MAFG 失调的机制。
Gastroenterology. 2018 Aug;155(2):557-571.e14. doi: 10.1053/j.gastro.2018.04.032. Epub 2018 May 5.
10
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.10号染色体单体与胶质母细胞瘤中表皮生长因子信号传导失调相关。
JAMA. 2009 Jul 15;302(3):276-89. doi: 10.1001/jama.2009.1022.

引用本文的文献

1
Ablation of Hepatocyte Derived-FGL1 Does Not Aggravate Metabolic Dysfunction-Associated Steatotic Liver Disease.肝细胞源性FGL1的消融不会加重代谢功能障碍相关脂肪性肝病。
FASEB J. 2025 Aug 31;39(16):e70962. doi: 10.1096/fj.202501997R.
2
Multiplex gene editing models of del(7q) reveal combined and loss drives clonal expansion and drug resistance.7号染色体长臂缺失(del(7q))的多重基因编辑模型揭示,联合缺失和功能丧失驱动克隆性扩增和耐药性。
Blood Neoplasia. 2025 Mar 3;2(2):100083. doi: 10.1016/j.bneo.2025.100083. eCollection 2025 May.
3
Small Extracellular Vesicle-Derived Nicotinamide Phosphoribosyltransferase (NAMPT) Induces Acyl-Coenzyme A Synthetase SLC27A4-Mediated Glycolysis to Promote Hepatocellular Carcinoma.小细胞外囊泡衍生的烟酰胺磷酸核糖基转移酶(NAMPT)诱导酰基辅酶A合成酶SLC27A4介导的糖酵解以促进肝细胞癌。
J Extracell Vesicles. 2025 Apr;14(4):e70071. doi: 10.1002/jev2.70071.
4
Unveiling the physiological impact of ESCRT-dependent autophagosome closure by targeting the VPS37A ubiquitin E2 variant-like domain.通过靶向VPS37A泛素E2变体样结构域揭示内体分选转运复合体(ESCRT)依赖性自噬体封闭的生理影响。
Cell Rep. 2024 Dec 24;43(12):115016. doi: 10.1016/j.celrep.2024.115016. Epub 2024 Nov 27.
5
Characterization of Expression-Based Gene Clusters Gives Insights into Variation in Patient Response to Cancer Therapies.基于表达的基因簇的特征分析为深入了解患者对癌症治疗反应的差异提供了线索。
Cancer Inform. 2024 Sep 4;23:11769351241271560. doi: 10.1177/11769351241271560. eCollection 2024.
6
Fibrinogen-like 1: A hepatokine linking liver physiology to hematology.纤维蛋白原样蛋白1:一种将肝脏生理学与血液学联系起来的肝源细胞因子。
Hemasphere. 2024 Jul 4;8(7):e115. doi: 10.1002/hem3.115. eCollection 2024 Jul.
7
Patterns of Aneuploidy and Signaling Consequences in Cancer.癌症中的非整倍体模式和信号后果。
Cancer Res. 2024 Aug 15;84(16):2575-2587. doi: 10.1158/0008-5472.CAN-24-0169.
8
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers.线粒体铁蛋白 2 是染色体 8p 缺失型癌症的合成致死靶点。
Genome Med. 2024 Jun 17;16(1):83. doi: 10.1186/s13073-024-01357-w.
9
Role of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy.纤维蛋白原样蛋白1在肝切除术后肿瘤复发中的作用
J Clin Transl Hepatol. 2024 Apr 28;12(4):406-415. doi: 10.14218/JCTH.2023.00397. Epub 2024 Mar 25.
10
The effect of trisomic chromosomes on spatial genome organization and global transcription in embryonic stem cells.三体染色体对胚胎干细胞空间基因组组织和全局转录的影响。
Cell Prolif. 2024 Aug;57(8):e13639. doi: 10.1111/cpr.13639. Epub 2024 Mar 29.

本文引用的文献

1
A tumour suppressor network relying on the polyamine-hypusine axis.依赖多胺-假尿嘧啶核苷轴的肿瘤抑制器网络。
Nature. 2012 Jul 12;487(7406):244-8. doi: 10.1038/nature11126.
2
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.整合基因组鉴定与肝细胞癌进展和患者生存相关的 8p 上的基因。
Gastroenterology. 2012 Apr;142(4):957-966.e12. doi: 10.1053/j.gastro.2011.12.039. Epub 2011 Dec 24.
3
Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.全基因组拷贝数分析鉴定出肝癌中的新型癌症基因。
Hepatology. 2011 Oct;54(4):1227-36. doi: 10.1002/hep.24495. Epub 2011 Aug 24.
4
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.通过肿瘤基因组筛选鉴定针对肝癌中扩增 FGF19 的治疗策略。
Cancer Cell. 2011 Mar 8;19(3):347-58. doi: 10.1016/j.ccr.2011.01.040.
5
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.一个独特的转移基因特征可用于预测早期肝细胞癌患者的肿瘤复发。
Cancer Res. 2010 Dec 15;70(24):10202-12. doi: 10.1158/0008-5472.CAN-10-2607.
6
Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi.使用四环素调控 RNAi 评估增殖和存活所需基因的工具包。
Nat Biotechnol. 2011 Jan;29(1):79-83. doi: 10.1038/nbt.1720. Epub 2010 Dec 5.
7
Integrative genomic profiling of human prostate cancer.人类前列腺癌的综合基因组分析。
Cancer Cell. 2010 Jul 13;18(1):11-22. doi: 10.1016/j.ccr.2010.05.026. Epub 2010 Jun 24.
8
High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.高分辨率分析膀胱癌 8p 染色体臂上的基因组改变。
Genes Chromosomes Cancer. 2010 Jul;49(7):642-59. doi: 10.1002/gcc.20775.
9
The landscape of somatic copy-number alteration across human cancers.人类癌症中体细胞拷贝数改变的全景。
Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.
10
Identification of DOK genes as lung tumor suppressors.鉴定 DOK 基因作为肺肿瘤抑制基因。
Nat Genet. 2010 Mar;42(3):216-23. doi: 10.1038/ng.527. Epub 2010 Feb 7.

染色体缺失中一组协同作用的抑癌候选基因。

A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.

机构信息

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

出版信息

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8212-7. doi: 10.1073/pnas.1206062109. Epub 2012 May 7.

DOI:10.1073/pnas.1206062109
PMID:22566646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3361457/
Abstract

The large chromosomal deletions frequently observed in cancer genomes are often thought to arise as a "two-hit" mechanism in the process of tumor-suppressor gene (TSG) inactivation. Using a murine model system of hepatocellular carcinoma (HCC) and in vivo RNAi, we test an alternative hypothesis, that such deletions can arise from selective pressure to attenuate the activity of multiple genes. By targeting the mouse orthologs of genes frequently deleted on human 8p22 and adjacent regions, which are lost in approximately half of several other major epithelial cancers, we provide evidence suggesting that multiple genes on chromosome 8p can cooperatively inhibit tumorigenesis in mice, and that their cosuppression can synergistically promote tumor growth. In addition, in human HCC patients, the combined down-regulation of functionally validated 8p TSGs is associated with poor survival, in contrast to the down-regulation of any individual gene. Our data imply that large cancer-associated deletions can produce phenotypes distinct from those arising through loss of a single TSG, and as such should be considered and studied as distinct mutational events.

摘要

在癌症基因组中经常观察到的大型染色体缺失通常被认为是肿瘤抑制基因(TSG)失活过程中的“两次打击”机制。我们使用肝细胞癌(HCC)的小鼠模型系统和体内 RNAi 来测试另一种假设,即这种缺失可能是由于选择性压力而削弱多个基因的活性而产生的。通过靶向人类 8p22 上经常缺失的基因的小鼠同源基因以及相邻区域,这些基因在其他几种主要上皮癌中丢失了约一半,我们提供了证据表明 8p 上的多个基因可以在小鼠中协同抑制肿瘤发生,并且它们的共抑制可以协同促进肿瘤生长。此外,在人类 HCC 患者中,功能验证的 8p TSG 的联合下调与生存不良相关,而不是单个基因的下调。我们的数据表明,与单个 TSG 丧失引起的表型相比,大型与癌症相关的缺失可产生明显不同的表型,因此应将其视为不同的突变事件并进行研究。